Inhibikase Therapeutics Announces a 1-for-6 Reverse Stock Split
/PRNewswire/ -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase or Company), a clinical-stage pharmaceutical company developing protein kinase...
Source: prnewswire.com
Page 21 - Multiple System Atrophy News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Multiple System Atrophy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Multiple System Atrophy Today - Breaking & Trending Today
Inhibikase Therapeutics Announces a 1-for-6 Reverse Stock Split
BOSTON and ATLANTA, June 29, 2023 /PRNewswire/ -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase or Company), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of
Source: valdostadailytimes.com
Alison Sellar: Former Aberdeenshire midwife and drama producer dies
Former Aberdeenshire midwife and drama director Alison Sellar has died aged 66. She was known for putting on productions at Glass.
Source: pressandjournal.co.uk
Inhibikase Therapeutics Announces Selection of the Bioequivalent Dose of IkT-001Pro and Provides Update on the '501' Bioequivalence Study
/PRNewswire/ -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) ("Inhibikase" or "Company"), a clinical-stage pharmaceutical company developing protein kinase...
Source: prnewswire.com
Inhibikase Therapeutics Initiates Medical and Patient Awareness Campaign for its Phase 2 '201' Trial Evaluating IkT-148009 in Parkinson's Disease
- Company to highlight the '201' trial at multiple regional seminars for physicians - - Up to 61% of clinical sites actively screening patients by close of 2Q23 - BOSTON and ATLANTA, June 21, 2023... | June 21, 2023
Source: marketscreener.com